2009 Annual Convention and Scientific Sessions
October 14-18, 2009
J.W. Marriott Starr Pass Resort, Tucson, AZ
Lectures are grouped according the the day on which they were scheduled. Click on links below to access available presentations. Not all lectures have been made available online.
WEDNESDAY
Dominic F. Glorioso, Jr, DO, FACOI
Treatment of Late Stage Cancer Point/Counterpoint
Kevin P. Hubbard, DO, FACOI
Treatment of Advanced Cancer The Point for Disease-Directed Therapies: Point/Counterpoint
Sandra P. Gomez, MD
Dying With Dignity: Our Contemporary Challenge
Leonard R. Hock, DO, FACOI
Opioid Myths
Dominic F. Glorioso, Jr., DO, FACOI
Opioid Resistant Pain
Shawn Martin
Preparing Your Practice for the Implementation of Health Information Technology
THURSDAY
Joanne Kaiser-Smith, DO, FACOI
Prediabetes: A Woman’s Perspective
Eileen Turner
Recovery Audit Contractors (RACs) and Medicare: The Who, What, When, Where, Why and How?
Susan Edgman-Levitan, PA
Through the Patient's Eyes: Enhancing Physician and Patient Satisfaction While Improving Practice Outcomes
Phillip Marcus, MD, MPH
Asthma Control 2009: The Impact of the Guidelines
Stephen Sokalski, DO, FACOI
Community Acquired Pneumonia Guidelines: What Went Wrong and Right
Gerald W. Blackburn, DO, FACOI
Neutropenic Precautions: Where's The Data?
Kevin P. Hubbard, DO, FACOI
Neutropenic Precautions: Do YOU Wear the Mask?
Stephen Rennard, MD
COPD 2009
FRIDAY
David V. Condoluci, DO, FACOI
AIDS/HIV Update
Thomas F. Morley, DO, FACOI
Pulmonary Embolism/DVT Update
Annette T. Carron, DO, FACOI
New Standards in the Physician's Role in Nursing Home Care
Joseph Giaimo, DO, FACOI; Timothy McNichol, JD
Washington Update
Ghassan M. Hammoud, MD, MPH
Viral Hepatitis B and C Therapy
Gerald W. Dryden, Jr., MD, MSPH
New Strategies for Biologic Use in Inflammatory Bowel
Disease
James M. Falko, DO
The Role of HDL in Vascular Disease and HDL Therapies on the Horizon: Implications for 2009 National Lipid Guidelines
Shani S. Saks, DO
Women and Coronary Artery Disease: Where Are We Now?
Leonard R. Hock, DO, FACOI
Minimizing Opioid Abuse and Pain
Thomas F. Jan, DO
- Ensuring Compliance and Avoiding Diversion
- Pain Management Agreement
- Consent for Chronic Opioid Therapy
Robert A. Pascucci, DO, FACOI
Hyperuricemia as a Marker for Atherogenesis and Heart Disease
Gabriel Contreras, MD
Medical Management of Lupus Nephritis, Current Therapies and Future Directions
Scott L. Girard, DO
How to Get There From Here
SATURDAY
Monica S. Carter, DO
Effective Treatment of Substance Abuse and Mental Health Issues in Underserved Populations
Thomas J. Mohr, DO, FACOI
Electronic Medical Records 2009 Update and Discussion Forum
Gerald W. Blackburn, DO, FACOI
Pandemic Influenza: Why We're NOT Prepared
Humayun J. Chaudhry, DO, MS, FACOI
Novel H1N1 Influenza A: Protecting the Public
Robert C. Hendel, MD
Appropriateness Criteria for Nuclear Cardiac and CTA Imaging
Craig W. Spellman, DO, FACOI; Janice A. Knebl, DO, FACOI
Aging and Testosterone Therapy
Craig W. Spellman, DO, FACOI
Diabetes and Hypertension
Sandra K. Willsie, DO, FACOI
Pocket Guide to COPD Diagnosis, Management and Prevention
Robert J. Chilton, DO, FACOI
Aspirin Resistance
Eric D. Good, DO
SVT: What's Important to Know and New Treatment Update
Jonathan Haft, MD
Are VAD patients Too Healthy to Ttransplant? An Update in Mechanical Circulatory Support
L. Bing Liem, DO, FACOI
Cardiac Resynchronization Therapy for Congestive Heart Failure: Its Advancements; Candidates for Therapy; and its Role in the Bigger Picture
SUNDAY
Robert Sandhaus, MD
Alpha 1 Antitrypsin Deficiency Colitis
Fredrick M. Abrahamian, DO, FACEP
Update on Clostridium difficile Colitis
Timothy J. Craig, DO, FACOI
A New Approach to Treating Hereditary Angioedema
For more information, contact Ms. Susan Stacy at the ACOI office.